Detection of vasostatin-1-specific CD8+ T cells in non-obese diabetic mice that contribute to diabetes pathogenesis

6Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chromogranin A (ChgA) is an antigenic target of pathogenic CD4+ T cells in a non-obese diabetic (NOD) mouse model of type 1 diabetes (T1D). Vasostatin-1 is a naturally processed fragment of ChgA. We have now identified a novel H2-Kd-restricted epitope of vasostatin-1, ChgA 36-44, which elicits CD8+ T cell responses in NOD mice. By using ChgA 36-44/Kd tetramers we have determined the frequency of vasostatin-1-specific CD8+ T cells in pancreatic islets and draining lymph nodes of NOD mice. We also demonstrate that vasostatin-1-specific CD4+ and CD8+ T cells constitute a significant fraction of islet-infiltrating T cells in diabetic NOD mice. Adoptive transfer of T cells from ChgA 36-44 peptide-primed NOD mice into NOD/severe combined immunodeficiency (SCID) mice led to T1D development. These findings indicate that vasostatin-1-specific CD8+ T cells contribute to the pathogenesis of type 1 diabetes in NOD mice.

Cite

CITATION STYLE

APA

Nikoopour, E., Krougly, O., Lee-Chan, E., Mansour Haeryfar, S. M., & Singh, B. (2016). Detection of vasostatin-1-specific CD8+ T cells in non-obese diabetic mice that contribute to diabetes pathogenesis. Clinical and Experimental Immunology, 185(3), 292–300. https://doi.org/10.1111/cei.12811

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free